Bookmark your favorite posts, get daily updates, and enjoy an ad-reduced experience.
Already have an account? Log in
Semble has raised a £30m Series C funding round to accelerate its healthcare management platform for outpatient providers.
Founded to address the deep fragmentation in how care is delivered, Semble connects and orchestrates every stage of the patient journey, helping solo clinicians, growing group practices and complex enterprise organisations deliver faster, safer and more patient-centred care.
The announcement comes as healthcare providers across the UK and Europe face mounting operational pressure caused by fragmented technology systems, rising patient demand and a generational shift towards private medical insurance and self-pay care models.
The new funding will drive the company’s expansion into the largest healthcare groups, advance its position as the AI orchestration layer underpinning modern care delivery, and cement its position in France.
The round was led by European growth investor Revaia with participation from Partech, plus continued backing from Mercia Ventures and Octopus Ventures.
“For years, the industry has tried to address complex systemic issues through disconnected point solutions, but fragmented technology often adds operational complexity for healthcare providers and creates an interrupted experience for patients,” says Christoph Lippuner, CEO and co-founder of Semble.
“What healthcare organisations need is intelligent orchestration across the entire care journey. The practices and groups that win over the next decade will be the ones that deliver the best patient experience end-to-end. This investment allows us to rapidly scale that vision across the UK and Europe.”
Bookmark your favorite posts, get daily updates, and enjoy an ad-reduced experience.
Already have an account? Log in
Registered in England & Wales at 124 City Roads, London, England, EC1V 2NX
–
Company No. 14998441
To provide the best experiences, we and our partners use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us and our partners to process personal data such as browsing behavior or unique IDs on this site and show (non-) personalized ads. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Click below to consent to the above or make granular choices. Your choices will be applied to this site only. You can change your settings at any time, including withdrawing your consent, by using the toggles on the Cookie Policy, or by clicking on the manage consent button at the bottom of the screen.
Leave a Reply